Clinical characteristics | Summary |
---|---|
Serous Ovarian Carcinoma Patients with Clinical Data | N=587 |
Number of Tumor Histopathology Image Series | 1216 |
Number of Histopathology Image Series of Adjacent Benign Tissue | 159 |
Age | 59.74 ± 11.53 years |
Race | |
 White | 498 (84.84 %) |
 Black or African American | 34 (5.79 %) |
 Asian | 20 (3.41 %) |
 American Indian or Alaska Native | 3 (0.51 %) |
 Native Hawaiian or Other Pacific Islander | 1 (0.17 %) |
 Race Not Available | 31 (5.28 %) |
Anatomical subdivision of the tumor | |
 Bilateral | 400 (68.14 %) |
 Left | 82 (13.97 %) |
 Right | 71 (12.10 %) |
 Not Available | 34 (5.79 %) |
Stage | |
 Stage I | 17 (2.90 %) |
 Stage II | 30 (5.11 %) |
 Stage III | 446 (75.98 %) |
 Stage IV | 89 (15.16 %) |
 Stage Not Available | 5 (0.85 %) |
Grade | |
 Grade 1 | 6 (1.02 %) |
 Grade 2 | 69 (11.75 %) |
 Grade 3 | 495 (84.33 %) |
 Grade 4 | 1 (0.17 %) |
 Grade Not Available | 16 (2.73 %) |
Transcriptomic subtypes | |
 Differentiated | 140 (23.85 %) |
 Immunoreactive | 159 (27.09 %) |
 Mesenchymal | 104 (17.72 %) |
 Proliferative | 150 (25.55 %) |
 Not Available | 34 (5.79 %) |